Items where Author is "Back, David"
Number of items: 12. 2021Back, David and Marzolini, Catia and Hodge, Catherine and Marra, Fiona and Boyle, Alison and Gibbons, Sara and Burger, David and Khoo, Saye. (2021) COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. British Journal of Clinical Pharmacology, 87 (1). pp. 212-213. 2020Hodge, Catherine and Marra, Fiona and Marzolini, Catia and Boyle, Alison and Gibbons, Sara and Siccardi, Marco and Burger, David and Back, David and Khoo, Saye. (2020) Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. The journal of antimicrobial chemotherapy, 75 (12). pp. 3417-3424. Stader, Felix and Khoo, Saye and Stoeckle, Marcel and Back, David and Hirsch, Hans H. and Battegay, Manuel and Marzolini, Catia. (2020) Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. The journal of antimicrobial chemotherapy, 75 (10). pp. 3084-3086. Back, David and Marzolini, Catia. (2020) The challenge of HIV treatment in an era of polypharmacy. Journal of the International AIDS Society, 23 (2). e25449. 2017Marzolini, Catia and Rajoli, Rajith and Battegay, Manuel and Elzi, Luigia and Back, David and Siccardi, Marco. (2017) Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes. Clinical Pharmacokinetics, 56 (4). pp. 409-420. 2016Marzolini, Catia and Gibbons, Sara and Khoo, Saye and Back, David. (2016) Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications. The Journal of antimicrobial chemotherapy, 71 (7). pp. 1755-1758. 2013Siccardi, Marco and Marzolini, Catia and Seden, Kay and Almond, Lisa and Kirov, Anna and Khoo, Saye and Owen, Andrew and Back, David. (2013) Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach. Clinical Pharmacokinetics, 52 (7). pp. 583-592. 2012de Roche, Mirjam and Siccardi, Marco and Stoeckle, Marcel and Livio, Françoise and Back, David and Battegay, Manuel and Marzolini, Catia. (2012) Efavirenz in an obese HIV-infected patient - a report and an in vitro-in vivo extrapolation model indicate risk of underdosing. Antiviral Therapy, 17 (7). pp. 1381-1384. Siccardi, Marco and Almond, Lisa and Schipani, Alessandro and Csajka, Chantal and Marzolini, Catia and Wyen, C. and Brockmeyer, Norbert H. and Boffito, M. and Owen, Andrew and Back, David. (2012) Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model. Clinical Pharmacology and Therapeutics, 92 (4). pp. 494-502. September 2011Marzolini, Catia and Back, David and Weber, Rainer and Furrer, Hansjakob and Cavassini, Matthias and Calmy, Alexandra and Vernazza, Pietro and Bernasconi, Enos and Khoo, Saye and Battegay, Manuel and Elzi, Luigia and Swiss HIV Cohort Study Members, . (2011) Ageing with HIV: medication use and risk for potential drug-drug interactions. The journal of antimicrobial chemotherapy, 66 (9). pp. 2107-2111. 2011Marzolini, Catia and Back, David and Weber, Rainer and Furrer, Hansjakob and Cavassini, Matthias and Calmy, Alexandra and Vernazza, Pietro and Bernasconi, Enos and Khoo, Saye and Battegay, Manuel and Elzi, Luigia and Swiss HIV Cohort Study Members, . (2011) Ageing with HIV : medication use and risk for potential drug-drug interactions. The journal of antimicrobial chemotherapy, Vol. 66, H. 9. pp. 2107-2111. 2010Marzolini, Catia and Elzi, Luigia and Gibbons, Sara and Weber, Rainer and Fux, Christoph and Furrer, Hansjakob and Chave, Jean-Philippe and Cavassini, Matthias and Bernasconi, Enos and Calmy, Alexandra and Vernazza, Pietro and Khoo, Saye and Ledergerber, Bruno and Back, David and Battegay, Manuel and Swiss HIV Cohort Study, . (2010) Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antiviral Therapy, 15 (3). pp. 413-423. |